Home > > North America And Global Radiofrequency Ablation Devices Market- Size, Share, Growth Rate, and Forecast
The North America Radiofrequency Ablation Devices market was valued at $1,033.2 Million in 2023, and is projected to reach $1,792.4 Million by 2030 growing at a CAGR of 8.24% from 2024 to 2030. Capital Equipment segment is expected to be the highest contributor to this market, with $430.5 Million in 2023, and is anticipated to reach $766.9 by 2030, registering a CAGR of 8.65%. Reusable Equipment segment is anticipated to reach $336.1 Million by 2030 with the highest CAGR of 9.26%. Capital Equipment and Disposable Equipment segments collectively expected to account for about 82.4% share of the North America Radiofrequency Ablation Devices market in 2023, with the former constituting around 41.7% share. Reusable Equipment and Capital Equipment segments are expected to witness significant growth rates at a CAGR of 9.26% and 8.65% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 59.2% in the overall North America Radiofrequency Ablation Devices market in 2023, and is anticipated to reach 61.5% by 2030. Product Disposable Equipment Capital Equipment Reusable Equipment Application Surgical Oncology Cardiology & Cardiac Rhythm Management Cosmetology Gynecology Pain Management BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA